pirfenidonenintedanibmycophenolate mofetiltreprostiniltocilizumab
…ow (see section on Current treatments). The antifibrotic drugs, pirfenidone and nintedanib, are established treatments for idiopathic pulmo…
3articles mentioning drugs
10drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: Lebrikizumab ×
Lebrikizumab
This drug is selected. Its supporting articles are shown below.
Articles mentioning Lebrikizumab
3 articles · page 1 of 1baricitinibabrocitinibdupilumablebrikizumabtralokinumabupadacitinib
…numab 300 mg biweekly; and -44.15% (95% CI -50.44 to -37.86) vs baricitinib 2 mg diary. Statistically significant differences were found be…
BaricitinibDupilumabTralokinumababrocitinibLebrikizumabupadacitinibEczema Area and Severity IndexNumeric Rating ScaleAtopic dermatitissecondary-level hospital+1 more
…12 (10–60) 4.5 (0–80) 7.5 (0–10) 0 (0–10) 8.5 (3–10) 3.5 (0–10) Baricitinib 22 (21–40) 1 (0–18) 16 (5–40) 1 (0–10) 6 (0–1) 0 (0–1) 8 (0–5) …